Association Between Coronary Artery Disease Testing in Patients with New-Onset Heart Failure and Heart Failure Readmission and Mortality.
Cheng-Wei HuangSiamak KohanIn-Lu Amy LiuJanet S LeeNicole C BaghdasaryanJoon S ParkJessica D VallejoChristopher C SubjectHuong NguyenMing-Sum LeePublished in: Journal of general internal medicine (2024)
In a contemporary and diverse cohort of patients hospitalized with new-onset HFrEF, CAD testing within 90 days of hospitalization was associated with a lower risk of HF readmission or all-cause mortality. Testing within 90 days after discharge was not associated with worse outcomes.
Keyphrases
- heart failure
- coronary artery disease
- end stage renal disease
- cardiovascular events
- acute heart failure
- ejection fraction
- newly diagnosed
- chronic kidney disease
- left ventricular
- peritoneal dialysis
- percutaneous coronary intervention
- atrial fibrillation
- cardiovascular disease
- cardiac resynchronization therapy
- type diabetes
- metabolic syndrome
- transcatheter aortic valve replacement
- glycemic control